Status:
UNKNOWN
QT Distance and P Dispersion in ECG in Patients Having Bronchoscopy in the ICU
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Ventilator-Induced Lung Injury
Pulmonary Atelectasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fiberoptic bronchoscopy (FOB) is one of the most useful procedures for diagnosing and treating respiratory illnesses to figure out symptoms like hemoptysis, wheezing, or cough. Furthermore, FOB is a f...
Detailed Description
For this study, it was planned to recruit 40 patients who would have FOB in the ICU of Abant İzzet Baysal University Anesthesia department. All intubated patients over 18 years of age who do not meet ...
Eligibility Criteria
Inclusion
- \* All intubated patients over 18 years of age
Exclusion
- Patients under the age of 18
- Pregnancy
- Patients using sedative drugs in the last 24 hours
- Hypersensitivity to the drugs used in the study
- Severe cardiac disorder (EF: \< 40)
- Patients using drugs that increase the QT interval (quinidine, lithium, procainamide, amiodarone, sotalol, phenothiazine, tricyclic antidepressants, disopyramide) or reduce the QT interval (digitals)
- Patients who have hypomagnesemia- hypocalcemia - hypo or hyperthermia - hypo or hypercalcemia - hyperkalemia - hyper or hypothyroidism - myocarditis - mitral heart prolapsus
Key Trial Info
Start Date :
June 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 25 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05434624
Start Date
June 25 2022
End Date
March 25 2024
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abant izzet baysal university
Bolu, Turkey (Türkiye), 14030